Restorbio Inc.
Adicet Bio discovers and develops allogeneic gamma delta T cell therapies and CAR-T therapies for autoimmune diseases, hematologic malignancies, and solid tumors.
8-KSep 29Latest SEC filing
Sep 28Latest story
Sign inSign inAdicet Bio discovers and develops allogeneic gamma delta T cell therapies and CAR-T therapies for autoimmune diseases, hematologic malignancies, and solid tumors.